Expression of Transcription Factor FOXC2 in Cervical Cancer and Effects of Silencing on Cervical Cancer Cell Proliferation |
Zheng, Chun-Hua
(Gynecology, The First Hospital of Jilin University)
Quan, Yuan (Gynecology, The First Hospital of Jilin University) Li, Yi-Yang (Gynecology, The First Hospital of Jilin University) Deng, Wei-Guo (Public Health, Jilin University) Shao, Wen-Jing (Gynecology, The First Hospital of Jilin University) Fu, Yan (Gynecology, The First Hospital of Jilin University) |
1 | VanTrappen PO, Ryan A, Carroll M, Lecoeur C (2002). A model for coexpression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer. Br J Cancer, 87, 537-44. DOI ScienceOn |
2 | Vreeburg M, Heitink MV, Damstra RJ, et al (2008). Lymphedemadistichiasis syndrome: a distinct type of primary lymphedema caused by mutations in the FOXC2 gene. Int J Dermatol, 47, 52-5. DOI ScienceOn |
3 | Wang WS, Yu SL, Yang XS, Chang SD, Hou JQ (2013) . Expression and Significance of Twist and E-cadherin in Ovarian Cancer Tissues. Asian Pac J Cancer Prev, 14, 669-72. DOI ScienceOn |
4 | Yang SH, Cheng HH, Wang ZH (2008). LYVE-1 and D2-40 in the study of early carcinoma and precancerous lesions of cervical squamous cell lymphatic microvessel in China detection. J Histochem Cytochem, 17, 588-92. |
5 | Yu YH, Chen HA, Chen PS, et al (2013). MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol. Oncogene, 32, 431-43. DOI ScienceOn |
6 | Pichler A, Zelcer N, Prior JL, et al (2005). In vivo RNA interference-mediated ablation of MDR1 P-glycoprotein. Clin Cancer Res, 11, 4487-94. DOI ScienceOn |
7 | Mani SA, Yang J, Brooks M, et al (2007). Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci USA, 104, 10069-74. DOI ScienceOn |
8 | Naohiro N, Koshi M, Takehiko Y, et al (2011). FOXC2 is a Novel Prognostic Factor in Human Esophageal SCC.Ann Surg Oncol, 18, 535-42. DOI |
9 | Nishida N, Mimori K, Yokobori T, et al (2011). FOXC2 is a novel prognostic factor in human esophageal SCC. Ann Surg Oncol, 18, 535-42. DOI |
10 | Petrova TV, Karpanen T, Norrmen C, et al (2004). Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasia. Nat Med, 10, 974-81. DOI ScienceOn |
11 | Putral LN, Bywater MJ, Gu W, et al (2005). RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin. Mol Pharmacol, 68, 1311-9. DOI ScienceOn |
12 | Roxanis I (2013). Occurrence and significance of epithelialmesenchymal transition in breast cancer. J Clin Pathol, 66, 517-21. DOI ScienceOn |
13 | Sano H, Leboeuf JP, Novitskiy SV, et al (2010). The FOXC2 transcription factor regulates tumor angiogenesis. Biochem Biophys Res Commun, 392, 201-6. DOI ScienceOn |
14 | Sendurai A.Mani, Jing Y, Mary B, et al (2007). Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers.Proc Natl Acad Sci USA, 104, 10069-74. DOI ScienceOn |
15 | Sima N, Wang W, Kong D, et al (2008). RNA interference against HPV16E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and P53.Apoptosis, 13, 273-81. DOI ScienceOn |
16 | Kreis NN, Sanhaji M, Kramer A, et al (2010). Restoration of the tumor suppressor p53 by down regulating cyclin B1 in human papilloma virus 16 /18 infected cancer cells. Oncogene, 29, 5591-603. DOI ScienceOn |
17 | Hayashi H, Kume T (2008). Foxc transcription factors directly regulate Dll4 and Hey2 expression by interacting with the VEGF-notch signaling pathways in endothelial cells.Plos One, 3, 2401. DOI ScienceOn |
18 | Itoh M, Nakagawa H (2013). A novel complex insertion-deletion mutation in the FOXC2 gene in a Japanese patient with lymphedema-distichiasis Syndrome. Eur J Dermatol, 23, 411-13. |
19 | Kreis NN, Sanhaji M, Kramer A, et al (2010). Restoration of the tumorsuppressor p53 by downregulating cyclin B1 in human papilloma-virus 16 /18-infected cancer cells.Oncogene, 29, 5591-603. DOI ScienceOn |
20 | Jiang XY, Liu WK, Zhang ZX, et al (2009). According to the HPV16 E7 gene RNA interference on the biological characteristics of CaSKi cell modern. Oncology, 17, 1029-31. |
21 | Kriederman BM, Myloyde TL, Witte MH, et al (2003). FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome. Hum Mol Genet, 12, 1179-85. DOI ScienceOn |
22 | Kuhnert F, Jessica RK, Thurston G (2011). Dll4-notch signaling as a therapeutic target in tumor angiogenesis. Vascular Cell, 3, 1-8. DOI ScienceOn |
23 | Kume T (2008). FOXC2 transcription factor: a newly described regulator of angiogenesis. Trends Cardiovasc Med, 18, 224-8. DOI ScienceOn |
24 | Kume T (2012). The role of FOXC2 transcription factor in tumor angiogenesis. J Oncol, 2012, 204593. |
25 | Lee MY, Shen MR (2012). Epithelial-mesenchymal transition in cervical carcinoma.Am J Transl Res, 4, 1-13. |
26 | Dellinger MT, Thome K, Bernas MJ, Erickson RP, Witte MH (2008). Novel FOXC2 missense mutation identified in patient with lymphedema-distichiasis syndrome and review. Lymphology, 41, 98-102. |
27 | Forouzanfar MH, Foreman KJ, Delossantos AM, et al (2011). Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lance Oct, 1461-84. |